CD14 and myeloid sarcoma: TLR2 in peripheral blood mononuclear cells (PBMCs) and CD14+ monocytes had a strong responsiveness to Pam2CSK4 stimulation in MS, suggesting that a high activity of TLR2 in MS may contribute to the pathogenesis of MS (50).